Targovax Pipeline


Product candidate
Cancer Indication
Combination with
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Pemetrexed/
cisplatin
KEYTRUDA®
ONCOS-102
Peritoneal
ODD*
IMFINZI® (Collab. with: Ludwig, CRI & AZ)
ONCOS-102
Prostate
DCVAC (Collab. with: SOTIO)
Gemcitabine
KEYTRUDA®
TG02
CPI synergy
TG + PD-1
Ongoing collaborator sponsored trials

ODD=Orphan Drug Incication
ODD*=ODD in Ovarian Cancer Perioteneal Subpopulation